Commit Biologics ApS
CVR 42642649 · Private limited company (ApS) · Active · Low risk
Commit Biologics ApS is a Private limited company (ApS), founded on , based in Aarhus C. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.4% over the next 12 months, which is 0.3 times the average for Danish companies. 4 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 37.9m and a net result of DKK -33.8m.
Bankruptcy risk for Commit Biologics ApS
0.3 × the average (1.41%) · higher risk than 57% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 42642649
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (5 years)
- Address
- Universitetsbyen 81
8000 Aarhus C - Municipality
- Aarhus
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 208k
- Auditor
- KOVSTED & SKOVGÅRD, REVISION & RÅDGIVNING, STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 4 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 97.7% |
| Current ratio | 4,008% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 4 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 1 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -23.4m | DKK -31.4m | DKK -13.6m |
| Net profit | DKK -33.8m | DKK -39.4m | DKK -17.3m |
| Equity | DKK 37.9m | DKK 23.2m | DKK 22.6m |
| Total assets | DKK 38.8m | DKK 24.5m | DKK 23.3m |
| Cash | DKK 30.4m | DKK 16.4m | – |
| Short-term debt | DKK 910k | DKK 1.2m | – |
| Avg. employees | 17 | 13 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Kovsted & Skovgård, Statsautoriseret revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 105 | ||
| 1 Jan 2024 – 31 Dec 2024 | 106 | ||
| 1 Jan 2023 – 31 Dec 2023 | 145 | ||
| 1 Sep 2021 – 31 Dec 2022 | 124 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Nick Stub Laursen | ||
| CEO | Dennis Vestergaard Pedersen | ||
| CEO | Heidi Gytz Olesen | ||
| CEO | Mikael Becher Lykkegaard Winkler | ||
| Board | Pieter Jeroen Bakker | Current | |
| Board | Nick Stub Laursen | Current | |
| Board | Roderick Verhelst | Current | |
| Board | Anker Gunvald Lundemose | Current | |
| Board | Janine Schuurman | Current | |
| Board | Thomas Lars Andresen | Current | |
| Board | Emiel Michiels | Current | |
| Board | Krishna Reddy Polu | ||
| Board | Eva Van Overmeire | ||
| Board | Mikkel Wandahl Pedersen | ||
| Owner (25%) | Novo Holdings A/S | Current | |
| Owner (15%) | Commit Biologics Holding ApS | Current | |
| Owner (25%) | Bioqube Factory Fund I CommV | Current | |
| Owner (15%) | Korys Investments | Current | |
| Owner (100%) | Commit Biologics Holding ApS | ||
| Owner (20%) | Novo Holdings A/S | ||
| Owner (5%) | BioInnovation Institute Fonden | ||
| Owner (33%) | Commit Biologics Holding ApS | ||
| Owner (20%) | Bioqube Factory Fund I CommV | ||
| Owner (5%) | BII Holdings A/S | ||
| Owner (25%) | Novo Holdings A/S | ||
| Owner (20%) | Commit Biologics Holding ApS | ||
| Owner (25%) | Bioqube Factory Fund I CommV | ||
| Owner (10%) | Korys Investments | ||
| Auditor | KOVSTED & SKOVGÅRD, REVISION & RÅDGIVNING, STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Founder | Commit Biologics Holding ApS | Current |
The CEOs' other companies
Nick Stub Laursen – 1 other companies
- Commit Biologics Holding ApS Active
Dennis Vestergaard Pedersen – 1 other companies
- Commit Biologics Holding ApS Active
Heidi Gytz Olesen – 1 other companies
- Commit Biologics Holding ApS Active
Mikael Becher Lykkegaard Winkler – 1 other companies
- Commit Biologics Holding ApS Active
Address history (1 moves)
| Universitetsbyen 81, 8000 Aarhus C | |
| Bakkelyparken 3B, 8680 Ry |
Other companies at the same address
- SymbioMatch ApS Active
Similar companies in Aarhus
- Resiliency Centre ApS Aarhus N
- SymbioMatch ApS Aarhus C
- AptaShape ApS Aarhus C
- Aptamist ApS Lystrup
- Mmimetika ApS Aarhus N
- MKR Finans APS Aarhus C
- Cystotech ApS Aarhus C
- IMCOR ApS Egå
- Økologisk Komplementarselskab ApS Aarhus N
- MyGold ApS Aarhus C
- UNIKUM Therapeutics ApS Risskov
- Solsten Diagnostics International ApS Aarhus N
Questions and answers about Commit Biologics ApS
Has Commit Biologics ApS gone bankrupt?
No, Commit Biologics ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Commit Biologics ApS?
Our model estimates a bankruptcy risk of 0.4% over the next 12 months (low risk), which is 0.3 times the average for Danish companies.
Who is the auditor of Commit Biologics ApS?
Commit Biologics ApS most recently used KOVSTED & SKOVGÅRD, REVISION & RÅDGIVNING, STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was Commit Biologics ApS founded?
Commit Biologics ApS was founded on 1 September 2021.
What is the equity of Commit Biologics ApS?
Equity was DKK 37.9m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.